Nancy Pelosi
Pharma Companies Spend Billions More on Stock Buybacks Than Developing Drugs, House Report Finds
The largest drugmakers spent $56 billion more on stock buybacks and dividends than on research and development from 2016 to 2020, according to a new House committee report.
Democrats Work to Finalize Infrastructure Package
Paul Pelosi Invests in Alphabet as Congress Weighs Breaking Up Big Tech
Dems Signaling Opposition to Pelosi’s Drug Pricing Bill Got 2.5x More Pharma Money
Pelosi-Controlled Committee Blocks Votes on Congressional Stock Trading
Paul Pelosi would have to give up his stock trading if bipartisan bills on blind trusts were allowed to advance.
Pelosi Ignored Her Own Caucus on Voting Reform For Years, Allowing States to Restrict Access
House Democrats outside of leadership have repeatedly proposed legislation on early voting and vote-by-mail, but Speaker Pelosi and the other leaders never got on board.